Retest improvement for minipool nucleic acid testing positive samples

Apply

Retest improvement for minipool nucleic acid testing positive samples

Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 2

Abstract

Objective To analyze the correlation between the distribution interval of minipool nucleic acid testing(NAT) positive CT value and the resolution rate, so as to improve the retest model and reduce residual risk of blood transfusion. Methods The resolution testing results by Cobas S201 system of our blood center from January 2017 to December 2021 were retrospective analyzed, and the retest model was developed based on the distribution interval of CT values. For minipool NAT HBV positive samples from March 2022 to March 2023, synchronous detection was conducted by Cobas S201 and Panther detection system, and the detection results were statistically analyzed. Results From 2017 to 2021, 474 were minipool NAT positive, among which 324 were HBV positive, accounting for 68.35%. From 2017 to 2020, the proportion of HBV positive per year was significantly higher than that of HCV and HIV(P<0.05). In resolution testing, 167 were HBV repeatable positive and 157 were HBV non-repeatable positive, accounting for 51.54% and 48.46% of HBV minipool NAT positive. HBV repeatable positive samples were with three intervals: CT value≤36, 36<CT value≤40 and CT value>40, with the resolution rate at 95.8%, 56.5% and 14.8% respectively(P<0.05). The proportion of 36<CT value≤40 interval in resolution positive group and resolution negative group was 80.8% and 66.2% respectively, and showed statistical differences compared with other two intervals(P<0.05). From March 2022 to March 2023, 65 were HBV positive in minipool NAT, with 5, 12, and 48 in CT value ≤36, CT value >40, 36<CT value≤40 intervals respectively, with the concordance rate at 100%, 100%, and 81.25% by Cobas S201 and Panther detcetion. Nine samples presented inconsistent results: 4 samples were resolution negative by Cobas S201 but positve by Panther, 3 were repeatable positive and 1 was non-repeatable positive by Cobas S201. These 9 samples were seen as unqualified, but according to original rules(non-repeatable positive samples were seen as qualified), missed detection of at least 3 samples might occur. Conclusion There was a certain proportion of non-repeatable positive samples in positive pool, and the rules (non-repeatable positive samples were seen as qualified) have a risk of missed detection. Those with 36<CT value ≤40 interval should be rested to ensure blood safety and save restest cost.

Authors and Affiliations

Yun HOU, Qiuxia FENG, Bei LI, Longmu ZHANG, Zhongsi YANG, Shuxian JIAO

Keywords

Causes of ABO forward and reverse grouping discrepancy: 75 cases

Objective To analyze the causes and solutions of ABO forward and reverse grouping discrepancy, and to ensure the safety of blood transfusion in clinical. Methods Samples from 75 patients with discrepancy between forward...

Abnormal blood transfusion compatibility test results caused by delayed hemolytic reaction: a case report and transfusion strategy

Objective To investigate the blood transfusion compatibility test results of a child with thalassemia after delayed hemolysis reaction, and to formulate transfusion strategies based on other clinical data to ensure the s...

EP ID EP738765
DOI 10.13303/j.cjbt.issn.1004549x.2024.02.011
Views 51
Downloads 0